Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

DBS share price near record highs as SGX bank rally cools, Fed decision ahead

DBS share price near record highs as SGX bank rally cools, Fed decision ahead

DBS Group Holdings shares hit a new 52-week high of S$59.57 before easing to S$59.40 in Wednesday afternoon trading, following a record close Tuesday. Phillip Securities downgraded DBS and OCBC to “neutral” after recent price gains, citing margin pressure from falling SORA rates. Traders await the U.S. Federal Reserve’s policy decision and DBS’s full-year results due Feb. 9.
28 January 2026
WiseTech Global (ASX:WTC) share price hits 52-week low as inflation shock fuels rate-hike bets

WiseTech Global (ASX:WTC) share price hits 52-week low as inflation shock fuels rate-hike bets

WiseTech Global shares fell 3.8% to A$60.70 in Sydney, hitting a 52-week low as traders braced for a possible Reserve Bank of Australia rate hike next week. Australia’s trimmed-mean CPI rose 3.4% year-on-year in the December quarter. The S&P/ASX 200 closed down 0.09%, with tech stocks leading declines. WiseTech reports half-year results on Feb. 25.
28 January 2026
South32 share price hits a 52-week high on ASX as rate bets shift and metals surge

South32 share price hits a 52-week high on ASX as rate bets shift and metals surge

South32 shares closed up 1.3% at A$4.56 in Sydney, hitting a 52-week high of A$4.59, with 15.35 million shares traded. Australian core inflation rose 0.9% for the quarter, prompting traders to price in a 73% chance of a rate hike by the RBA next week. The S&P/ASX 200 slipped 0.09% to 8,933.9 after the inflation report. Spot gold surged past $5,200 an ounce as the U.S. dollar weakened.
Paladin Energy share price jumps on uranium’s $91 rally — what to watch next for ASX:PDN

Paladin Energy share price jumps on uranium’s $91 rally — what to watch next for ASX:PDN

Paladin Energy shares rose 5.4% to A$13.94 on Wednesday, near a 52-week high, as uranium futures hovered at $91.15 a pound, their highest in almost two years. Paladin reported a 16% jump in quarterly production and plans to release interim results Feb. 12. Short interest in Paladin slipped to 11.87%. The ASX is now closed, with attention turning to whether the uranium rally will continue.
28 January 2026
Lynas Rare Earths share price rises as ASX shuts; RBA hike bets and U.S. rare-earth deal loom

Lynas Rare Earths share price rises as ASX shuts; RBA hike bets and U.S. rare-earth deal loom

Lynas Rare Earths closed up 1.2% at A$16.20 as the S&P/ASX 200 slipped 0.1%. Core inflation rose 3.4% year-over-year, pushing swap markets to price in a 73% chance of a Feb. 3 RBA rate hike. USA Rare Earth said the Trump administration plans to back a $1.6 billion funding deal. Lynas flagged a 30% drop in NdPr output last quarter due to power disruptions and maintenance.
28 January 2026
Macquarie (ASX:MQG) share price slips as Australia inflation shocks rate bets — what investors watch next

Macquarie (ASX:MQG) share price slips as Australia inflation shocks rate bets — what investors watch next

Macquarie Group shares fell 1.1% to A$212.84 on Wednesday after hotter-than-expected inflation data raised market bets on a Reserve Bank of Australia rate hike next week. The trimmed mean CPI rose 0.9% in the December quarter, lifting the annual rate to 3.4%. The ASX 200 slipped 0.09%, while the Australian dollar hovered just below 70 U.S. cents. Macquarie made no new disclosures to the market.
Mineral Resources (ASX:MIN) share price slips after inflation shock as quarterly report looms

Mineral Resources (ASX:MIN) share price slips after inflation shock as quarterly report looms

Mineral Resources fell 0.9% to A$63.41 in Sydney after touching a record A$65.08, ahead of its December-quarter results due Thursday. Rising core inflation pushed expectations for a Reserve Bank rate hike next week, pressuring risk assets. The S&P/ASX 200 slipped 0.09%, led by declines in IT and healthcare. China’s record iron ore imports and volatile lithium prices remain key factors for the miner.
DroneShield share price sinks after ASX cash-flow update; what to watch next for ASX:DRO

DroneShield share price sinks after ASX cash-flow update; what to watch next for ASX:DRO

DroneShield shares fell 5.5% to A$3.95 after the company posted quarterly cash receipts of A$63.5 million and positive operating cash flow of A$7.7 million. Investors weighed unaudited December-quarter figures and the timing of contract deliveries ahead of the full-year audit. The company ended the quarter with A$210.4 million in cash. Next reporting updates are scheduled for February 24.
Northern Star Resources share price jumps 3.6% as gold tops $5,200; investors eye Feb 12 results

Northern Star Resources share price jumps 3.6% as gold tops $5,200; investors eye Feb 12 results

Northern Star Resources closed up 3.6% at A$28.71 as gold hit a record $5,247.21 an ounce before settling near $5,243.58. The company recently cut its FY26 production forecast and raised cost guidance to A$2,600–A$2,800 an ounce. Australian inflation data has fueled speculation of a February rate hike. Traders are watching U.S. dollar moves and upcoming Reserve Bank and Federal Reserve decisions.
28 January 2026
1 85 86 87 88 89 535

Stock Market Today

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Go toTop